ACS Laboratory tests Florida medical cannabis following the Department of Health’s Office of Medical Marijuana Use (OMMU) rules. It provides compliant Certificates of Analysis (COA) detailing the results.
Start Compliance TestingContact Us To Learn MoreACS Laboratory offers a la carte research & development (R&D) cannabis tests so MMTCs can gather critical insights during product development. R&D tests allow brands to refine formulations, improve product quality, and optimize ingredients. Results are not reported to the OMMU.
Start R+D TestingContact Us To Learn MoreMedical Use of Marijuana Statute 381.986
Section 986Medical Marijuana Pesticide Use
Rule: 64-4.013Renewal Application Requirementsfor MMTCs
Rule: 64-4.201MMTC Regulatory Compliance Testing:
Rule 64-4.212Lab Certification and Testing Standards
Rule 64-4.016MMTC Solvent-Based Extraction
Rule: 64-4.209Packaging and Labeling Standards
Rule 64-4.206Edible Products
Rule 64-4.001ACS Laboratory recommends testing hemp crops every week after the flowering phase for each plant variety to ensure they test below the 0.3% THC limit. From a compliance perspective, FL state regulations require that hemp flower be sampled for compliance by the certified laboratory 15-30 days before harvest. Cultivators must submit a Notice of Harvest to the Department at least 30 days prior to the intended harvest date, per Rule 5B-57.014. And schedule sample collection for compliance testing about 15 to 30 days before harvest. In addition to testing THC potency for compliance, ACS Laboratory offers various R&D hemp testing options in the pre-harvest phase that ensure healthy growth and development. These include pre-planting soil and elemental analysis, micronutrient testing to pinpoint mineral deficiencies, and measuring THCA , Delta 9, and CBDA, which contribute significantly to total THC and CBD levels in final products.
The 2018 Farm Bill removed hemp from the federal Controlled Substances List, making it legal to sell and ship hemp-based CBD products containing less than 0.3% THC in the US as long as they comply with applicable federal, state, and local laws. This includes the FDA’s FD&C.